hydroxymaprotilin has been researched along with Depressive Disorder in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (64.29) | 18.7374 |
1990's | 10 (35.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breyer-Pfaff, U; Gaertner, HJ; Giedke, H | 1 |
Binz, U; Wendt, G | 1 |
Bornová, L; Filip, V; Höschl, C; Karen, P; Prasko, J; Prasková, H; Seifertová, D | 1 |
Andrade, C | 1 |
Albrecht, V; David, I; Filip, V; Höschl, C; Palus, M; Prasková, H; Seifertová, D | 1 |
Benkert, O; Gerken, A; Holsboer, F; Steiger, A | 1 |
Angst, J; Delini-Stula, A; Stassen, HH | 1 |
Katz, RJ; Landau, P; Lott, M; Waldmeier, P | 1 |
Parker, G | 1 |
Bornová, L; David, I; Filip, V; Höschl, C; Karen, P; Seifertová, D | 1 |
Fukuda, Y; Inukai, T; Noguchi, S | 1 |
Hole, G; Keller, F; Steiner, B; Straub, R; Wolfersdorf, M | 1 |
Faltus, F; Janecková, E; Koníková, M; Krekule, P; Molcan, J; Mrna, B; Náhunek, K; Pazdírek, S; Svestka, J; Zapletálek, M | 1 |
Cesková, E; Misurec, J; Náhunek, K; Obrovská, V; Rysánek, R; Svestka, J; Wendt, G | 1 |
Katz, RJ | 1 |
Binz, U; Hole, G; Steiner, B; Wendt, G; Wolfersdorf, M | 1 |
Berger, M; Emrich, HM; Riemann, D; von Zerssen, D | 1 |
Blansjaar, BA; Dijken, WA; Haffmans, J; Kamp, JS; Kramer, HJ; Nolen, WA; van de Putte, JJ | 2 |
Bakish, D; Browne, M; Horn, E; Hrdina, PD; Lapierre, YD | 1 |
Binz, U; Hole, G; Metzger, R; Wendt, G; Wolfersdorf, M | 1 |
Axmann, D; Breyer-Pfaff, U; Gaertner, H; Giedke, H; Rein, W | 1 |
Lautin, A; Novatt, A; Peselow, ED; Rohrs, C; Rotrosen, J; Siekierski, J; Wolkin, A | 1 |
Gnirss, FA | 1 |
Giedke, H; Heimann, H | 1 |
Giedke, H; Heimann, H; Rein, W | 1 |
Blaschke, D; Dieterle, D; Laakmann, G; Schmauss, M | 1 |
Dijken, WA; Kamp, JS; Nolen, WA; van de Putte, JJ | 1 |
1 review(s) available for hydroxymaprotilin and Depressive Disorder
Article | Year |
---|---|
Time course of improvement under antidepressant treatment: a survival-analytical approach.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Models, Statistical; Psychiatric Status Rating Scales; Single-Blind Method; Time Factors | 1993 |
21 trial(s) available for hydroxymaprotilin and Depressive Disorder
Article | Year |
---|---|
[The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Topics: Affect; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Maprotiline; Motivation; Psychiatric Status Rating Scales; Psychometrics; Sleep Stages | 1982 |
Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Hospitalization; Humans; Male; Maprotiline; Middle Aged; Placebos; Probability; Treatment Outcome | 1993 |
Not significantly different is not the same as significantly similar.
Topics: Amitriptyline; Antidepressive Agents; Data Interpretation, Statistical; Depressive Disorder; Humans; Maprotiline; Norepinephrine | 1993 |
Dynamics of the effects of levoprotiline and maprotiline on EEG in patients with major depressive episodes (DSM-III-R).
Topics: Adult; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Humans; Male; Maprotiline; Middle Aged | 1993 |
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Growth Hormone; Humans; Hydrocortisone; Male; Maprotiline; Middle Aged; Neurosecretion; Norepinephrine; Penile Erection; Prolactin; Psychiatric Status Rating Scales; Sleep; Sleep, REM; Stereoisomerism; Testosterone | 1993 |
Time course of improvement under antidepressant treatment: a survival-analytical approach.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Models, Statistical; Psychiatric Status Rating Scales; Single-Blind Method; Time Factors | 1993 |
A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Maprotiline; Norepinephrine; Psychiatric Status Rating Scales | 1993 |
Recovery from depression: triggers and time patterns.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Drug Administration Schedule; Humans; Maprotiline; Personality Inventory; Psychometrics; Survival Analysis; Time Factors; Treatment Outcome | 1996 |
[Results of a clinical trial of levoprotiline].
Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged | 1992 |
[Psychopathologic and psychophysiologic follow-up of inpatient depressed patients with standardized treatment with clomipramine and oxaprotiline].
Topics: Adult; Antidepressive Agents; Arousal; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Hospitalization; Humans; Male; Maprotiline; Middle Aged; Personality Tests; Psychometrics | 1991 |
CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
Topics: Anthracenes; Antidepressive Agents; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Psychiatric Status Rating Scales; Pulse; Random Allocation | 1988 |
Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Depressive Disorder; Dexamethasone; Female; Fluvoxamine; Humans; Hydrocortisone; Male; Maprotiline; Middle Aged; Norepinephrine; Oximes; Prognosis; Psychiatric Status Rating Scales; Serotonin | 1987 |
Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
Topics: Adult; Anthracenes; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Oximes; Personality Disorders; Psychological Tests; Psychometrics | 1988 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Nomifensine; Oximes; Psychological Tests; Tranylcypromine | 1988 |
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Female; Humans; Male; Maprotiline; Middle Aged; Psychiatric Status Rating Scales | 1988 |
Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Psychiatric Status Rating Scales | 1987 |
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
Topics: Amitriptyline; Anthracenes; Antidepressive Agents; Arousal; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychological Tests; Psychopathology | 1986 |
The dexamethasone suppression test and response to placebo.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Humans; Maprotiline; Placebos; Sertraline | 1986 |
[Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
Topics: Adult; Amitriptyline; Anthracenes; Antidepressive Agents; Contingent Negative Variation; Depressive Disorder; Double-Blind Method; Electrophysiology; Evoked Potentials, Auditory; Female; Humans; Male; Maprotiline; Middle Aged; Nortriptyline; Random Allocation | 1987 |
Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Topics: Adult; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Electroencephalography; Female; Humans; Male; Maprotiline; Middle Aged; Psychiatric Status Rating Scales | 1985 |
L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Clinical Trials as Topic; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Fluvoxamine; Follow-Up Studies; Humans; Maprotiline; Middle Aged; Oximes; Random Allocation; Serotonin Antagonists; Stereoisomerism; Tranylcypromine | 1985 |
7 other study(ies) available for hydroxymaprotilin and Depressive Disorder
Article | Year |
---|---|
[Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
Topics: Amitriptyline; Antidepressive Agents; Arousal; Depressive Disorder; Double-Blind Method; Electroencephalography; Evoked Potentials; Glycols; Humans; Maprotiline; Methoxyhydroxyphenylglycol | 1984 |
Possible contributory role of the central histaminergic system in the forced swimming model.
Topics: Animals; Antidepressive Agents; Brain Chemistry; Central Nervous System; Depressive Disorder; Disease Models, Animal; Histamine; Male; Maprotiline; Methylhistamines; Mice; Motor Activity; Pyrilamine; Swimming | 1992 |
Comparative study of levoprotiline and amitriptyline in endogenous depressions.
Topics: Adult; Aged; Amitriptyline; Anthracenes; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged | 1989 |
Position of levoprotiline in the treatment of acute endogenous depression.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged | 1989 |
Long term treatment with oxaprotiline in patients with major depression.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged; Psychiatric Status Rating Scales | 1989 |
Depression and sleep disorders. The optical isomers of oxaprotiline and their effect on sleep parameters in healthy subjects.
Topics: Adult; Anthracenes; Depressive Disorder; Humans; Male; Maprotiline; Norepinephrine; Sleep; Sleep Wake Disorders; Sleep, REM | 1986 |
Psychophysiological aspects of depressive syndromes.
Topics: Adult; Amitriptyline; Arousal; Autonomic Nervous System; Depressive Disorder; Electroencephalography; Evoked Potentials, Auditory; Female; Galvanic Skin Response; Humans; Inhibition, Psychological; Male; Maprotiline; Middle Aged | 1987 |